Flow balancing system and method, especially for citrate

• US 9,005,150 B2
• Filed: 07/18/2011
• Issued: 04/14/2015
• Est. Priority Date: 10/15/2003
• Status: Active Grant

• Current Assignee: Baxter Healthcare SA (Baxter International Inc.), Baxter International Inc.
• Original Assignee: Baxter Healthcare SA (Baxter International Inc.), Baxter International Inc.
• Inventors: Ware, Lee C., Boehnlein, Arnold F.
• Primary Examiner(s): MENDEZ, MANUEL A
• Application Number:
  US13/185,147
• Publication Number:
  US 20110266221A1
• Time in Patent Office: 1,366 Days
• Field of Search: 604 401- 616, 604 65- 67, 604/131
• US Class Current: 604/5.04
• CPC Class Codes: A61M 1/3434 with pre-dilution and post-dilution
• CPC Class Codes: A61M 1/3437 downstream of the filter, e.g. post-dilution with filtrate
• CPC Class Codes: A61M 1/3441 Substitution rate control as a function of the ultrafiltration rate
• CPC Class Codes: A61M 1/3451 the difference in weight between both ultra-filtrate and substitution reservoir being used as control signal
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 5/142 Pressure infusion, e.g. using pumps
• CPC Class Codes: A61M 5/16827 controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths infusion of multiple fluids without using a controller A61M5/1407
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/67 for remote operation

Abstract

A renal failure therapy system includes a blood pump; a citrate pump; and a control unit configured to automatically control the blood pump and the citrate pump to achieve a citrate flowrate that is based on at least a blood flowrate.

Claims

1. A blood filtration system comprising:

a blood filtration machine, including;

a) a blood filtration machine controller housed within the blood filtration machine;

(b) a blood pump housed integrally with the blood filtration machine, the blood pump positioned and arranged to pump blood through a blood line;

c) a filter in fluid communication with the blood line, the filter including a dialysis solution chamber;

d) a citrate pump housed integrally with the blood filtration machine, the citrate pump in fluid communication with the blood line and positioned and arranged to pump a citrate anticoagulant solution into the filter; and

(e) a dialysis solution pump housed integrally with the blood filtration machine, the dialysis solution pump positioned and arranged to pump a dialysis solution into the dialysis solution chamber;

a substitution solution fluid source; and

a substitution solution infusion pump including a substitution solution infusion pump controller, the substitution solution infusion pump arranged to pump substitution fluid from the substitution solution fluid source into the blood line, the substitution solution infusion pump located external to the blood filtration machine, wherein

the blood filtration machine controller is configured to automatically control the citrate pump at least in part based on a flowrate of the blood pumped by the blood pump, and

the blood filtration machine controller is operable with the substitution solution infusion pump controller to automatically control the substitution solution infusion pump at least in part based upon an operation of the blood pump.

2. The blood filtration system of claim 1, wherein the blood filtration machine controller is further configured to cause the citrate pump to deliver a total prescribed volume of citrate.

3. The blood filtration system of claim 1, wherein the blood filtration machine controller is further configured to operate with the substitution solution infusion pump controller to perform a treatment selected from the group consisting of:

continuous renal replacement therapy, dialysis, hemofiltration and any combination thereof.

4. The blood filtration system of claim 1, wherein the blood filtration machine controller automatically controls the flowrate of the citrate anticoagulant solution at least in part based upon a flow rate prescription inputted by a physician.

5. The blood filtration system of claim 1, wherein the blood filtration machine controller automatically controls the citrate pump based upon at least a blood pump rate.

6. A method of controlling a flowrate of a citrate anticoagulant solution in a renal therapy machine having a renal therapy controller, comprising:

pumping blood through a blood circuit with a blood pump of the renal therapy machine, which is controlled by the renal therapy machine controller;

pumping citrate anticoagulant through the blood circuit of the renal therapy machine with a citrate anticoagulant pump of the renal therapy machine, which is controlled by the renal therapy machine controller;

pumping a substitution solution from a substitution solution source into the blood circuit with a substitution solution infusion pump located external to the renal therapy machine, the substitution solution infusion pump controlled by a substitution solution infusion pump controller; and

causing the renal therapy machine controller to;

(a) adjust a flowrate of the citrate anticoagulant based upon a flowrate of the blood; and

(b) operate with the substitution solution infusion pump controller to adjust an operation of the substitution solution infusion pump based upon an operation of the blood pump.

7. The method of claim 6, which includes

(i) pumping filtrate from the blood circuit with a filtrate pump of the renal therapy machine;

and

(ii) monitoring the blood flowrate, the citrate flowrate, the substitution solution flowrate and the filtrate flowrate to determine a net fluid loss or gain.

8. The method of claim 7, which includes comparing the net fluid loss or gain with an expected fluid loss or gain.

9. The method of claim 6, which includes adjusting the citrate anticoagulant flowrate based upon at least one of:

(i) a blood flowrate signal;

(ii) a substitution solution flowrate signal and (iii) a filtrate flowrate signal.

10. The method of claim 6, which includes pumping dialysate solution into a filter in communication with the blood circuit.

11. The method of claim 10, which includes adjusting the citrate anticoagulant flow rate based upon a dialysate flowrate signal.